Abstract
Temporal lobe epilepsy (TLE) is the most common form of adult epilepsy and frequently evolving drug resistance. Although there is growing consensus that noncoding ribonucleic acids (ncRNAs) are modulators of TLE, the knowledge about the deoxyribonucleic acid (DNA) methylation patterns of ncRNAs in TLE remains limited. In the current study, we constructed DNA methylation profiles from 30 TLE patients and 30 healthy controls for ncRNAs, primarily focusing on long ncRNAs (lncRNAs) and microRNAs (miRNAs), by reannotating data of DNA methylation BeadChip. Statistics analyses have revealed a global hypermethylation pattern in miRNA and lncRNA gene in TLE patients. Bioinformatic analyses have found aberrantly methylated miRNAs and lncRNAs are related to ion channel activity, drug metabolism, mitogen-activated protein kinase (MAPK) signaling pathway, and neurotrophin signaling pathway. Aberrantly methylated ncRNA and pathway target might be involved in TLE development and progression. The methylated and demethylated ncRNAs identified in this study provide novel insights for developing TLE biomarkers and potential therapeutic targets.
Similar content being viewed by others
References
(1993) Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia 34:592–596
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D et al (2011) Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 52(Suppl 7):2–26
Chang BS, Lowenstein DH (2003) Epilepsy. N Engl J Med 349:1257–1266
Tellez-Zenteno JF, Hernandez-Ronquillo L (2012) A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat 2012:630853
Loscher W, Luna-Tortos C, Romermann K, Fedrowitz M (2011) Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected. Curr Pharm Des 17:2808–2828
Blumcke I, Coras R, Miyata H, Ozkara C (2012) Defining clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hippocampal sclerosis. Brain Pathol 22:402–411
Kobow K, Auvin S, Jensen F, Loscher W, Mody I, Potschka H et al (2012) Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia 53:1868–1876
Kobow K, El-Osta A, Blumcke I (2013) The methylation hypothesis of pharmacoresistance in epilepsy. Epilepsia 54(Suppl 2):41–47
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Djuranovic S, Nahvi A, Green R (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336:237–240
Alsharafi WA, Xiao B, Abuhamed MM, Luo Z (2015) miRNAs: biological and clinical determinants in epilepsy. Front Mol Neurosci 8:59
Jimenez-Mateos EM, Henshall DC (2013) Epilepsy and microRNA. Neuroscience 238:218–229
Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G et al (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18:1087–1094
Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159
Kung JT, Colognori D, Lee JT (2013) Long noncoding RNAs: past, present, and future. Genetics 193:651–669
Wu P, Zuo X, Deng H, Liu X, Liu L, Ji A (2013) Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res Bull 97:69–80
Roberts TC, Morris KV, Wood MJ (2014) The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease. Philos Trans R Soc Lond Ser B Biol Sci 369(1652):20130507
Bond AM, Vangompel MJ, Sametsky EA, Clark MF, Savage JC, Disterhoft JF et al (2009) Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci 12:1020–1027
Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484–492
Sato F, Tsuchiya S, Meltzer SJ, Shimizu K (2011) MicroRNAs and epigenetics. FEBS J 278:1598–1609
Li Y, Zhang Y, Li S, Lu J, Chen J, Wang Y et al (2015) Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer. Sci Rep 5:8790
Zhou Y, Zhang X, Klibanski A (2012) MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 48:R45–R53
Miller-Delaney SF, Bryan K, Das S, McKiernan RC, Bray IM, Reynolds JP et al (2015) Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain 138:616–631
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen HW, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077
Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152–D157
Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S et al (2014) Ensembl 2014. Nucleic Acids Res 42:D749–D755
Zou Q, Mao Y, Hu L, Wu Y, Ji Z (2014) miRClassify: an advanced web server for miRNA family classification and annotation. Comput Biol Med 45:157–160
Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A et al (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33:2697–2706
Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F et al (2012) GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22:1760–1774
Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789
Zhi H, Ning S, Li X, Li Y, Wu W, Li X (2014) A novel reannotation strategy for dissecting DNA methylation patterns of human long intergenic non-coding RNAs in cancers. Nucleic Acids Res 42:8258–8270
Das S, Bryan K, Buckley PG, Piskareva O, Bray IM, Foley N et al (2013) Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene 32:2927–2936
Morita S, Takahashi RU, Yamashita R, Toyoda A, Horii T, Kimura M et al (2012) Genome-wide analysis of DNA methylation and expression of microRNAs in breast cancer cells. Int J Mol Sci 13:8259–8272
Cho S, Jang I, Jun Y, Yoon S, Ko M, Kwon Y et al (2013) MiRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic Acids Res 41:D252–D257
Dennis GJ, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25–29
Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30
Jiang Q, Ma R, Wang J, Wu X, Jin S, Peng J et al (2015) LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data. BMC Genomics 16(Suppl 3):S2
Li JH, Liu S, Zhou H, LH Q, Yang JH (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92–D97
Kobow K, Kaspi A, Harikrishnan KN, Kiese K, Ziemann M, Khurana I et al (2013) Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 126:741–756
Kobow K, Blumcke I (2014) Epigenetic mechanisms in epilepsy. Prog Brain Res 213:279–316
Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290
Takeda K, Ichijo H (2002) Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes Cells 7:1099–1111
Correa SA, Eales KL (2012) The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J Signal Transduct 2012:649079
Shao Y, Wang C, Hong Z, Chen Y (2016) Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats. J Neurochem 136:1096–1105
Gambardella A, Labate A (2014) The role of calcium channel mutations in human epilepsy. Prog Brain Res 213:87–96
Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R et al (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127:2682–2692
Bienvenu T, Diebold B, Chelly J, Isidor B (2013) Refining the phenotype associated with MEF2C point mutations. Neurogenetics 14:71–75
Nowakowska BA, Obersztyn E, Szymanska K, Bekiesinska-Figatowska M, Xia Z, Ricks CB et al (2010) Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Am J Med Genet B Neuropsychiatr Genet 153B:1042–1051
Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond Ser B Biol Sci 361:1545–1564
Miller FD, Kaplan DR (2001) Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 58:1045–1053
Wang J, Yu JT, Tan L, Tian Y, Ma J, Tan CC et al (2015) Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy. Sci Rep 5:9522
Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656
Hu K, Xie YY, Zhang C, Ouyang DS, Long HY, Sun DN et al (2012) MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 13:115
Liu W, Rong Y, Baudry M, Schreiber SS (1999) Status epilepticus induces p53 sequence-specific DNA binding in mature rat brain. Brain Res Mol Brain Res 63:248–253
Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16:1337–1345
Peng W, Si S, Zhang Q, Li C, Zhao F, Wang F et al (2015) Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J Exp Clin Cancer Res 34:79
Blumcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A et al (2013) International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia 54:1315–1329
Chateauvieux S, Morceau F, Dicato M, Diederich M (2010) Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010:479364
Ekstrom L, Skilving I, Ovesjo ML, Aklillu E, Nylen H, Rane A et al (2015) miRNA-27b levels are associated with CYP3A activity in vitro and in vivo. Pharmacol Res Perspect 3:e192
Tominaga N, Kosaka N, Ono M, Katsuda T, Yoshioka Y, Tamura K et al (2015) Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun 6:6716
Kalani A, Kamat PK, Familtseva A, Chaturvedi P, Muradashvili N, Narayanan N et al (2014) Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism. J Cereb Blood Flow Metab 34:1212–1222
Kamphuis WW, Derada TC, Reijerkerk A, Romero IA, de Vries HE (2015) The blood-brain barrier in multiple sclerosis: microRNAs as key regulators. CNS Neurol Disord Drug Targets 14:157–167
van Vliet EA, Da CAS, Redeker S, van Schaik R, Aronica E, Gorter JA (2007) Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130:521–534
van Vliet EA, Aronica E, Gorter JA (2014) Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance. Neuroscience 277:455–473
Roessler J, Ammerpohl O, Gutwein J, Hasemeier B, Anwar SL, Kreipe H et al (2012) Quantitative cross-validation and content analysis of the 450 k DNA methylation array from Illumina, Inc. BMC Res Notes 5:210
Acknowledgements
This study was supported by the National Natural Science Foundation of China (NNSFC), grant no. 81401078 to H.Y.L and no. 81371435 to B.X.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Wenbiao Xiao and Yuze Cao contributed equally to this work.
Electronic Supplementary Material
.
Fig. S1
Detail information about clinical subgroups of TLE. a Bar graphs illustrating the distribution of disease onset age and disease course for 30 TLE patients. Red bars represent disease course and blue bars for disease onset age. Red serial number represents drug-resistant patient, blue serial number for drug-responsive patient. b Pie graphs illustrating the rate distribution of detail antiepileptic drug for 30 TLE patients. c Pie graphs illustrating the rate distribution of monotherapy and combination drug therapy for 30 TLE patients. (GIF 177 kb)
.
.
Fig. S2
A depiction of MAPK pathway in KEGG database. The KEGG annotated MAPK pathway as significantly enriched for TLE. Proteins or complexes targeted by differentially methylated miRNAs or lncRNAs are indicated in red character. Two important genes (CACN and MEF2C) are target genes and meanwhile are reported implicated in epilepsy or seizure phenotype in PubMed database and are indicated in red character and yellow background. (GIF 75 kb)
.
.
Table S1
(PDF 90 kb)
.
Table S2
(PDF 40 kb)
.
Table S3
(PDF 14 kb)
.
Table S4
(PDF 14 kb)
.
Table S5
(PDF 56 kb)
Rights and permissions
About this article
Cite this article
Xiao, W., Cao, Y., Long, H. et al. Genome-Wide DNA Methylation Patterns Analysis of Noncoding RNAs in Temporal Lobe Epilepsy Patients. Mol Neurobiol 55, 793–803 (2018). https://doi.org/10.1007/s12035-016-0353-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-016-0353-x